Moderna Inc (MRNA)

Return on assets (ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	-3,561,000	-4,714,000	8,362,000	12,202,000	-747,064
Total assets	US$ in thousands	14,142,000	18,426,000	25,858,000	24,669,000	7,337,000
ROA		-25.18%	-25.58%	32.34%	49.46%	-10.18%

December 31, 2024 calculation

ROA = Net income ÷ Total assets
= $-3,561,000K ÷ $14,142,000K
= -25.18%

Based on the provided data, Moderna Inc's return on assets (ROA) has shown significant fluctuations over the years.

In December 31, 2020, the ROA was reported at -10.18%, indicating that the company's assets were not generating a positive return during that period. However, a drastic improvement was seen in December 31, 2021, with the ROA soaring to 49.46%, suggesting that the company's assets were able to generate substantial returns.

The positive trend continued in December 31, 2022, with an ROA of 32.34%, indicating that the company was effectively utilizing its assets to generate profits. However, a sharp decline was observed in December 31, 2023, with the ROA dropping to -25.58%, signifying a potential decrease in asset efficiency and profitability.

Furthermore, the trend worsened in December 31, 2024, with the ROA further declining to -25.18%, indicating continued challenges in asset utilization and overall profitability for Moderna Inc.

Overall, the fluctuating ROA figures highlight the variability in Moderna Inc's ability to generate returns from its assets over the years, potentially influenced by factors such as operational efficiency, economic conditions, and strategic decisions.